Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
KNSA 01.06.2025
Date of Upcoming Event:2025-01-13
Name of Upcoming Event:43rd Annual J.P. Morgan Healthcare Conference
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) --Kiniksa Pharmaceuticals International, plc(Nasdaq: KNSA) today announced that it will present at the 43rdAnnual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time).
A live webcast of Kiniksa’s presentation will be accessible through the Investors section of the company’s website atwww.kiniksa.com.A replay of the event will also be available on Kiniksa’s website within approximately 48 hours after the event.
About KiniksaKiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa’s immune-modulating assets are based on strong biologic rationale or validated mechanisms, target a spectrum of underserved cardiovascular and autoimmune conditions, and offer the potential for differentiation. For more information, please visitwww.kiniksa.com.
Every Second Counts!®
Kiniksa Investor ContactJonathan Kirshenbaum(781) 829-3949jkirshenbaum@kiniksa.com
Kiniksa Media ContactTyler Gagnon(781) 431-9100tgagnon@kiniksa.com
